Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-22

Clinical Trial Update: Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial of nitisinone (NTBC) in different age groups for alkaptonuria has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitisinone (Nitisinone)

Snippet

Sponsor: University of California, San Diego | Conditions: Alkaptonuria | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-04-22